共有 50 笔近期内部人交易记录记录，涉及 Indaptus Therapeutics, Inc. (INDP), 包括 39 笔买入 和 2 笔卖出. 内部人买入总额为 $2.81M 内部人卖出总额为 $100.73K.
近期活跃的重要内部人包括 Lazar David E., Dai Junyi, Yao Yun. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — INDP
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-23 |
Lazar David E. |
Director |
知情卖出 |
700,000 |
- |
- |
- |
| 2026-03-23 |
Dai Junyi |
Chief Executive Officer |
未知 |
- |
- |
- |
11,250,000 |
| 2026-03-23 |
Yao Yun |
10 Percent Owner |
未知 |
- |
- |
- |
41,991,000 |
| 2026-03-23 |
Sino Lion Ventures Ltd |
10 Percent Owner |
未知 |
- |
- |
- |
38,895,000 |
| 2026-02-26 |
Mcmurdo Matthew Charles |
Director |
未知 |
- |
- |
- |
25,000 |
| 2026-02-26 |
Jabbour Jerome D |
Director |
未知 |
- |
- |
- |
- |
| 2026-02-26 |
Jabbour Jerome D |
Director |
限制性股票授予 (RSU) |
25,000 |
$2.06 |
$51.5K |
25,000 |
| 2026-02-11 |
Meckler Jeffrey A |
Co-chief Executive Officer |
股份退回 |
12,136 |
$8.30 |
$100.73K |
- |
| 2026-01-20 |
Ben-tzvi Avraham |
Director |
限制性股票授予 (RSU) |
25,000 |
- |
- |
25,100 |
| 2026-01-08 |
Natan David |
Director |
未知 |
- |
- |
- |
- |
| 2026-01-07 |
Natan David |
Director |
限制性股票授予 (RSU) |
25,000 |
$2.69 |
$67.25K |
25,000 |
| 2025-12-23 |
Ben-tzvi Avraham |
Director |
限制性股票授予 (RSU) |
25,000 |
$1.95 |
$48.75K |
25,000 |
| 2025-12-22 |
Lazar David E. |
Co-chief Executive Officer |
未知 |
- |
- |
- |
- |
| 2025-12-22 |
Ben-tzvi Avraham |
Director |
未知 |
- |
- |
- |
100 |
| 2025-12-22 |
Meckler Jeffrey A |
10 Percent Owner, Officer: Co-chief Executive Officer |
限制性股票授予 (RSU) |
216,617 |
$2.03 |
$439.73K |
229,929 |
| 2025-12-22 |
Linscott Walt Addison |
Chief Operating Officer |
限制性股票授予 (RSU) |
54,421 |
$2.03 |
$110.47K |
54,426 |
| 2025-12-22 |
Sassi Nir |
Chief Financial Officer |
限制性股票授予 (RSU) |
26,758 |
$2.03 |
$54.32K |
26,758 |
| 2025-12-22 |
Newman Michael James |
CSO and Director |
限制性股票授予 (RSU) |
52,204 |
$2.03 |
$105.97K |
101,074 |
| 2025-07-27 |
Meckler Jeffrey A |
Chief Executive Officer |
限制性股票授予 (RSU) |
6,068 |
$8.30 |
$50.38K |
13,312 |
| 2025-06-10 |
Hayes William B |
Director |
限制性股票授予 (RSU) |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Martell Robert |
Director |
限制性股票授予 (RSU) |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Maddaluna Anthony J |
Director |
限制性股票授予 (RSU) |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Pomerantz Roger |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.33 |
$9.9K |
30,000 |
| 2025-06-10 |
Karah Hila |
Director |
限制性股票授予 (RSU) |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2025-06-10 |
Gilbert Mark John |
Director |
限制性股票授予 (RSU) |
12,500 |
$0.33 |
$4.13K |
12,500 |
| 2024-11-25 |
Meckler Jeffrey A |
CEO and Director |
限制性股票授予 (RSU) |
42,553 |
$1.05 |
$44.68K |
42,553 |
| 2024-10-09 |
Meckler Jeffrey A |
CEO and Director |
限制性股票授予 (RSU) |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Linscott Walt Addison |
Chief Operating Officer |
限制性股票授予 (RSU) |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Waltzman Roger J. |
Chief Medical Officer |
限制性股票授予 (RSU) |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Sassi Nir |
Chief Financial Officer |
限制性股票授予 (RSU) |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-10-09 |
Newman Michael James |
10 Percent Owner, Officer: CSO and Director |
限制性股票授予 (RSU) |
75,000 |
$1.11 |
$82.88K |
75,000 |
| 2024-08-08 |
Meckler Jeffrey A |
CEO and Director |
限制性股票授予 (RSU) |
84,932 |
$1.70 |
$144.38K |
84,932 |
| 2024-06-06 |
Hayes William B |
Director |
限制性股票授予 (RSU) |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Martell Robert |
Director |
限制性股票授予 (RSU) |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Maddaluna Anthony J |
Director |
限制性股票授予 (RSU) |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Pomerantz Roger |
Director |
限制性股票授予 (RSU) |
30,000 |
$2.63 |
$78.9K |
30,000 |
| 2024-06-06 |
Karah Hila |
Director |
限制性股票授予 (RSU) |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-06-06 |
Gilbert Mark John |
Director |
限制性股票授予 (RSU) |
12,500 |
$2.63 |
$32.88K |
12,500 |
| 2024-01-22 |
Meckler Jeffrey A |
CEO and Director |
限制性股票授予 (RSU) |
100,000 |
$1.74 |
$174K |
100,000 |
| 2024-01-22 |
Linscott Walt Addison |
Chief Operating Officer |
限制性股票授予 (RSU) |
75,000 |
$1.74 |
$130.5K |
75,000 |
| 2024-01-22 |
Waltzman Roger J. |
Chief Medical Officer |
限制性股票授予 (RSU) |
75,000 |
$1.74 |
$130.5K |
75,000 |
| 2024-01-22 |
Sassi Nir |
Chief Financial Officer |
限制性股票授予 (RSU) |
40,000 |
$1.74 |
$69.6K |
40,000 |
| 2024-01-22 |
Newman Michael James |
10 Percent Owner, Officer: CSO and Director |
限制性股票授予 (RSU) |
43,250 |
$1.74 |
$75.26K |
43,250 |
| 2023-08-14 |
Anderson Glen R. |
10 Percent Owner |
知情买入 |
23,934 |
$2.34 |
$56.01K |
1,190,400 |
| 2023-08-11 |
Anderson Glen R. |
10 Percent Owner |
知情买入 |
35,064 |
$2.12 |
$74.34K |
1,166,466 |
| 2023-08-10 |
Anderson Glen R. |
10 Percent Owner |
知情买入 |
44,354 |
$1.94 |
$86.05K |
1,131,402 |
| 2023-08-07 |
Waltzman Roger J. |
Officer |
未知 |
- |
- |
- |
- |
| 2023-08-07 |
Waltzman Roger J. |
Chief Medical Officer |
限制性股票授予 (RSU) |
90,000 |
$1.85 |
$166.5K |
90,000 |
| 2023-05-25 |
Hayes William B |
Director |
限制性股票授予 (RSU) |
12,500 |
$1.82 |
$22.75K |
12,500 |
| 2023-05-25 |
Maddaluna Anthony J |
Director |
限制性股票授予 (RSU) |
12,500 |
$1.82 |
$22.75K |
12,500 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
